Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;15(2):109-14.
doi: 10.1016/j.pathophys.2008.04.003. Epub 2008 Jul 29.

Risk factors and mechanisms of non-alcoholic steatohepatitis

Affiliations

Risk factors and mechanisms of non-alcoholic steatohepatitis

Chantal A Rivera. Pathophysiology. 2008 Aug.

Abstract

The worldwide proportion of overweight and obese individuals has increased yearly for more than a decade. Along with rates of obesity, the incidence of co-morbid conditions such as type 2 diabetes, cardiovascular disease and liver disease has also increased. The form of liver disease associated with obesity is termed non-alcoholic steatohepatitis (NASH) due to the histological similarities to livers of chronic alcoholics. NASH has been observed in adult as well as pediatric populations; however, the etiology of this disease is still unknown. This review outlines some of the risk factors commonly associated with NASH and describes molecular mechanisms proposed to underlie disease pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of steatohepatitis risk factors and proposed mechanism
Over nutrition can lead to enhanced circulating fatty acids and possibly endotoxemia. Current data suggests that these agents stimulate intracellular signaling via interaction with TLR-4, resulting in the production of cytokines and chemokines, which stimulate inflammation, steatosis and ultimately lead to NASH. Several risk factors such as degree of adiposity, race and the presence of T2DM enhance the severity of NASH.

Similar articles

Cited by

References

    1. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007;22:293–303. - PubMed
    1. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48–53. - PubMed
    1. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002;34:255–262. - PubMed
    1. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002;288:1728–1732. - PubMed
    1. Harnois F, Msika S, Sabate JM, Mechler C, Jouet P, Barge J, Coffin B. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2006;16:183–188. - PubMed